<table border="0" cellpadding="0" cellspacing="0" width="margin: auto auto auto 40.85pt" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Beta-Blockers </content>
<content stylecode="bold"></content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">The concomitant use of beta-blockers and Glucagon for Injection may increase the risk of a temporary increase in heart rate and blood pressure.  <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">The increase in blood pressure and heart rate may require therapy in patients with coronary artery disease.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Insulin</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Insulin reacts antagonistically towards glucagon.  <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Monitor blood glucose when Glucagon for Injection is used as a diagnostic aid in diabetes patients.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Indomethacin</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">The concomitant use of indomethacin and Glucagon for Injection may lead to hypoglycemia. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Monitor blood glucose levels during glucagon treatment of patients taking indomethacin.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Anticholinergic Drugs</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">The concomitant use of anticholinergic drugs and Glucagon for Injection increase the risk of gastrointestinal adverse reactions due to additive effects on inhibition of gastrointestinal motility. <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Concomitant use is not recommended.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Warfarin</content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Clinical Impact:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Glucagon may increase the anticoagulant effect of warfarin. <br/>
</td>
</tr>
<tr>
<td align="right" stylecode="Lrule Rrule" valign="top">
<content stylecode="italics">Intervention:</content>
<br/>
</td>
<td stylecode="Rrule" valign="top">Monitor patients for unusual bruising or bleeding, as adjustments in warfarin dosage may be required.<br/>
</td>
</tr>
</tbody>
</table>